NCT02601807Unknown不适用
A Randomised Controlled Trial to Assess the Benefits of ActiPatch-Pulsed Shortwave Therapy for Chronic Lower Back Pain
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Pain-related disability, indexed by the Oswestry Disability Index (ODI)
研究概览
简要总结
The ActiPatch is a cutaneous device which is CE marked approved for relief of pain. It is taped over the affected area and stimulation at a high frequency is reported to alleviate pain with no sensation. However there is no class 1 evidence for this on back pain. By randomising patients between application of an active device or a dummy device and assessment of disability and pain scores at two weeks, the efficacy or otherwise can be established. Low back pain is a major health problem and if effective this has major economic implications as the device is cheap and safe.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participant is willing and able to give informed consent for participation in the trial.
- •In the Investigator's opinion, is able and willing to comply with all trial requirements.
- •Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial.
- •Male or female ages 18-90 years old with stable chronic low back pain
- •≥3 months duration of chronic low back pain
- •a current VAS pain rating ≥5/10
- •no radiating pain below the knee
- •≥75% back or buttock pain rather than lower extremity pain
- •Able to complete and tolerate treatment for the study period.
排除标准
- •Female participant who is pregnant
- •Significant renal or hepatic impairment.
- •Prior home use of pulsed shortwave therapy
- •Prior history of spinal fusion or failed spinal surgery syndrome.
- •Laminectomy, laminotomy or discectomy within 12 months of enrollment.
- •Diagnostic or interventional injections or any low back surgeries not mentioned above, including radiofrequency neuroablation within 6 months of enrollment.
- •Any addition of strong opiates, pregabalin and gabapentin to the treatment regime during the course of the trial
- •Current implanted cardiac demand pacemakers, defibrillators, cardiac pumps, spinal stimulators or other implanted electronic devices.
- •Patients using personal home based electrical stimulation devices
- •Patients with other concomitant illnesses (e.g., malignancy, osteoporosis) which, in the opinion of the investigator, would preclude successful patient participation will also be excluded
- •Active psychiatric disorders (as evidenced by use of antipsychotic or medication).
- •Patients diagnosed with history of significant mood disorder will be excluded (depression or anxiety with adequate control would be acceptable).
- •Scheduled elective surgery or other procedures requiring general anaesthesia during the trial.
- •Participant with life expectancy of less than 6 months, or inappropriate for placebo medication.
- •Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
- •Participants who have participated in another research trial involving an investigational product in the past 12 weeks.
- •Participants who are not able to understand verbal or written English, and for whom adequate translation/interpretation cannot be readily obtained.
结局指标
主要结局
Pain-related disability, indexed by the Oswestry Disability Index (ODI)
时间窗: Change from baseline ODI score at 2 weeks
次要结局
- Quality of life, indexed by the EQ-5D-5L questionnaire(Change from baseline EQ-5D-5L scores at 2 weeks)
- Medication intake(Change from baseline medication intake rate over the course of 2 weeks, recorded daily during the 2 week period by participant as part of a pain diary)
- Pain related disability, indexed by the Roland Morris Instrument(Change from baseline Roland Morris Instrument scores at 2 weeks)
- Subjective pain, indexed by Visual analogue pain scale(Change from baseline visual analogue score over the course of 2 weeks, recorded daily during the 2 week period by participant as part of a pain diary)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back PainChronic Low Back PainNCT03240146BioElectronics Corporation60
已完成
2 期
Abatacept for the Treatment of Myositis-associated Interstitial Lung DiseaseMyositisInterstitial Lung DiseaseNCT03215927Rohit Aggarwal, MD20
已完成
不适用
Pulse Shortwave Therapy in Cervical OsteoarthritisCervical OsteoarthritisNCT03542955BioElectronics Corporation180
已完成
2 期
Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)Delayed Onset Muscle SorenessNCT02602353Lead Chemical Co., Ltd.42
招募中
4 期
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)Tennis ElbowLateral EpicondylitisNCT03718637Henry Ford Health System40